GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuphoria Therapeutics Inc (STU:B1N0) » Definitions » FFO

Neuphoria Therapeutics (STU:B1N0) FFO


View and export this data going back to 2021. Start your Free Trial

What is Neuphoria Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.


Neuphoria Therapeutics Business Description

Traded in Other Exchanges
Address
100 Summit Dr, Burlington, MA, USA, 01803
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.